reactive oxygen species drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (13)
Papers in which this entity is mentioned.
- Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers. (2023)
- The effects of gestational choline supplementation on cerebellar Purkinje cell number in the sheep model of binge alcohol exposure during the first trimester-equivalent. (2022)
- Transcriptomic analyses of gastrulation-stage mouse embryos with differential susceptibility to alcohol. (2021)
- Macrophage Polarization States in the Tumor Microenvironment. (2021)
- Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
- Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
- A pooled mutational analysis identifies ionizing radiation-associated mutational signatures conserved between mouse and human malignancies. (2017)
- Gene-environment interactions in development and disease. (2017)
- New insights into the generation and role of de novo mutations in health and disease. (2016)
- Effects of alcohol on the endocrine system. (2013)
- BRCA1 and BRCA2: different roles in a common pathway of genome protection. (2011)
- Fetal alcohol spectrum disorders: experimental treatments and strategies for intervention. (2011)
- Fetal alcohol spectrum disorders: research challenges and opportunities. (2011)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| reactive oxygen species | drug | 64 | 96 |
| reactive oxygen species | phenotype | 18 | 21 |